Giorgia Guglielmi

How the human microbiota may help treat tough infections

Microbiota-based approaches could help researchers expand the therapeutic toolkit for fighting antibiotic resistance and treating tough infections.

Even mild COVID can have long-lasting effects on gut microbes

The findings of a recent study suggest that even mild cases of COVID-19 can disrupt the gut microbiota.

Incredibly diverse bacteria inhabit the guts of hunter-gatherers in Tanzania

The findings of a recent study provide insights into how industrialized lifestyles have influenced the composition of the human gut microbiota.

Five bacterial signatures define the healthy human gut microbiota

The findings of a recent study may help researchers to characterize the composition of the human gut microbiota in health and disease.

Microbiota transplant may alleviate intestinal side effects of cancer immunotherapy

The findings of a recent study suggest that FMT is an effective strategy to mitigate the intestinal side effects of cancer immunotherapy.

Gut microbiota may be linked to Alzheimer’s disease risk, clinical study finds

Understanding how gut microbes are linked to preclinical Alzheimer’s disease could help to identify markers of disease risk.

Antibiotics may alter gut microbes in ways that hinder cancer immunotherapy

The findings of a recent study suggest that targeting the interactions between MAdCAM-1 and specific receptors on the surface of immune cells may help to improve immunotherapy outcomes.

Vaginal seeding may benefit babies born by C-section, small clinical study shows

The findings of a recent study suggest that vaginal seeding is safe and may normalize the gut microbiota in infants born by C-section.

Key immune molecule helps keep commensal microbes in check

IgA can modulate the exposure and immune response to commensal microbes, and its levels determine the severity of immune dysregulation and clinical symptoms in people with IgA deficiency.

Nanomedicine improves symptoms of inflammatory bowel disease in mice

The findings of a new study suggest that the new nanomedicine approach can improve the delivery of TNF-α-siRNA in people with IBD.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top